Acute Ischemic Stroke From Large Vessel Occlusion

Neurology
0
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Penumbra
PenumbraALAMEDA, CA
1 program
Penumbra System with Separator 3DN/A1 trial
Active Trials
NCT01584609Completed198Est. Dec 2017

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
PenumbraPenumbra System with Separator 3D

Clinical Trials (1)

Total enrollment: 198 patients across 1 trials

NCT01584609PenumbraPenumbra System with Separator 3D

A Randomized, Concurrent Controlled Trial to Assess the Safety and Effectiveness of the Separator 3D as a Component of the Penumbra System in the Revascularization of Large Vessel Occlusion in Acute Ischemic Stroke

Start: Apr 2012Est. completion: Dec 2017198 patients
N/ACompleted

Related Jobs in Neurology

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 companies competing in this space